DYN
Dyne Therapeutics, Inc.
Stock
$15.20−0.62 (−3.92%)Close Oct 2, 2026
- Capital expenditures, 2025
- $1.9M
- YoY, 2025
- −19.2%
- 5-year CAGR
- +10.6%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $1.9M | −19.2% |
| 2024 | $2.4M | +225.9% |
| 2023 | $729K | −76.2% |
| 2022 | $3.1M | −15.2% |
| 2021 | $3.6M | +211.6% |
| 2020 | $1.2M | −29.5% |
| 2019 | $1.6M | — |